Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Medicine meets earth science: geologists unearth the atomic fingerprints of cancer
Scientists at the University of Colorado Boulder and Princeton University, USA, have, for the first…
Simulated chemistry: New AI platform designs tomorrow’s cancer drugs
Scientists at UC San Diego, USA, have developed a machine learning algorithm to simulate the…
Regulating cholesterol levels might be the key to improving cancer treatment
A team of researchers from Aarhus University, Denmark, has made a remarkable discovery that could…
Research validates TCM liver-breast cancer theory: fatty liver linked to deteriorating breast cancer
- Antibody-drug conjugate highly effective in preventing recurrence in patients with early stage HER2+ breast cancer
- 30 minutes of exercise increases the proportion of tumour-killing white blood cells in blood
- Novel inhibitor HVH-2930 showing promise in overcoming trastuzumab resistance in HER2-positive breast cancer
Indian and Pakistani women diagnosed with more aggressive breast cancer at younger age
Indian and Pakistani women are diagnosed with breast cancer, including more aggressive forms of the disease, at a younger age,…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.